Skip to content

Validity and Reliability of the Kinesthetic Motor Imagery of Pelvic Floor Muscle Contraction Questionnaire in Turkish

The Turkish Validity and Reliability of the Kinesthetic Motor Imagery of Pelvic Floor Muscle Contraction Questionnaire

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06882694
Enrollment
0
Registered
2025-03-18
Start date
2025-10-25
Completion date
2025-12-26
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motor İmagery Ability, Pelvic Floor

Keywords

pelvic floor, motor imagery ability, reliability, validity

Brief summary

The aim of this study is to adapt the questionnaire named "Kinesthetic Motor Imagery of Pelvic Floor Muscle Contraction Questionnaire (KMI-PFQ)" into Turkish in healthy women and to introduce it to the literature as a valid and reliable questionnaire.

Interventions

BEHAVIORALPelvic Floor Imagery Questionairre

This intervention consists of a questionairre

Sponsors

Kutahya Health Sciences University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Being between 18-30 years old * Understanding and speaking Turkish * Being willing to participate in the study * Not having any neurological or orthopedic problems * Not having any pelvic floor pathology diagnosed by a specialist physician

Exclusion criteria

* Having any previous or current pelvic floor pathology * Not understanding or speaking Turkish

Design outcomes

Primary

MeasureTime frameDescription
Kinesthetic Motor Imagery of Pelvic Floor Muscle Contraction Questionnaire20 minutesThe KMI-PFQ is a 5-item scale through which women reported their ability and mental effort for imagining pelvic floor muscle contractions.The two dimensions of this instrument (ability and mental effort of the imagined contraction) were scored from zero to 5 for each item. In this imagining ability dimension, responses ranged from zero (the contraction is impossible to feel) to 5 (the imagined contraction is very easy to feel). In the mental effort dimension, the responses ranged from zero (the mental effort to perform the contraction was none to 5 (the mental effort to perform the (imagined) contraction was very intense). Considering that the items for the mental effort dimension are reversed, the maximum score that could be obtained was 25 points for each dimension, with 50 being the maximum possible for the whole questionnaire.

Secondary

MeasureTime frameDescription
Movement Imagination Questionnaire *MIQ-320 minutesThe MIQ-3 developed by Williams et al. will be used to assess individuals' imagery abilities. The HIA-3 is a self-report psychometric measurement method that measures both kinesthetic imagery and visual imagery abilities of individuals. The test consists of 12 items. The test assesses both kinesthetic imagery abilities and visual imagery (internal visual imagery and external visual imagery) abilities of individuals. The test includes 3 different ways of imagining 4 movements. After each imagery action, individuals are asked to rate how easy/difficult it is to perform this mental action. Individuals score their mental actions for Internal Visual Imagery and External Visual Imagery with a 7-point Likert-type scale; 1 = Very hard to see, 7 = Very easy to see; for kinesthetic imagery, 1 = Very hard to feel, 7 = Very easy to feel.
Vividness of Visual Imagery Questionnaire (VVIQ-12)10 minutesThe VVIQ-12 was another instrument we used in validating our KMI-PFQ. The VVIQ is a 12-item self-report scale used to assess the vividness of visual images. The 12 items were structured into four factors: moving space images, familiar images, detailed objects recall, and images creative skill. For each item, the participant can score from 1 to 5 according to how easy it is to generate mental images as clear and realistic as normal vision.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026